CompletedNCT02986503

European Study in Bone Sarcoma Patients Over 40 Years

Studying Bone sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Italian Sarcoma Group
Principal Investigator
Stefano Ferrari, MD
Italian Sarcoma Group
Intervention
Doxorubicin+cisplatin+ifosfamide(drug)
Enrollment
100 enrolled
Eligibility
41-65 years · All sexes
Timeline
2002 – 2016

Study locations (3)

Collaborators

Scandinavian Sarcoma Group · Cooperative Osteosarcoma Study Group

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02986503 on ClinicalTrials.gov

Other trials for Bone sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Bone sarcoma →

← Back to all trials